Kaixuan Du
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kaixuan Du has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Cai Zhang
Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
12 shared publications - Ke Chen
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
12 shared publications - Lijie Zhou
Department of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China
12 shared publications - Lilong Liu
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
12 shared publications - Sayu Xiao
Department of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
12 shared publications - Yiheng Dai
Department of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
12 shared publications
Latest Publications
- Open Access
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
Supplementary data related to Figure 1-2
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
Supplementary data related to Figure 1-2
- Open Access
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
Supplementary data related to Figure 3
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
Supplementary data related to Figure 3
- Open Access
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S8 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
Restoration of MLYCD reversed resistance to ENZ in PCa, related to Figure 7
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
Restoration of MLYCD reversed resistance to ENZ in PCa, related to Figure 7
- Open Access
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
Restoration of MLYCD expression depleted intracellular malonyl-CoA to repress lipid accumulation and activat PERK mediated endoplasmic reticulum stress signaling pathways
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
Restoration of MLYCD expression depleted intracellular malonyl-CoA to repress lipid accumulation and activat PERK mediated endoplasmic reticulum stress signaling pathways
- Open Access
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1-4 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
The basic clinical information of the human specimens analyzed in the manuscript
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1-4 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
The basic clinical information of the human specimens analyzed in the manuscript
- Open Access
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
MLYCD was downregulated in PCa
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
MLYCD was downregulated in PCa
- Open Access
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
Ran K141 malonylation promoted AR nuclear localization, related to Figure 5
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
Ran K141 malonylation promoted AR nuclear localization, related to Figure 5
- Open Access
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S9 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
The levels of MLYCD expression and Ran K141 malonylation correlates with the clinical prognosis of PCa patients
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
The levels of MLYCD expression and Ran K141 malonylation correlates with the clinical prognosis of PCa patients
- Open Access
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
Ran K141 malonylation increased the AR transcriptional activity in PCa cells
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
Ran K141 malonylation increased the AR transcriptional activity in PCa cells
- Open Access
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
MLYCD decreased the levels of Ran K141 malonylation, related to Figure 4
- 14 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation
MLYCD decreased the levels of Ran K141 malonylation, related to Figure 4